Literature DB >> 7812198

Hypercalcemia, parathyroid hormone-related protein expression and human T-cell leukemia virus infection.

D Prager1, J D Rosenblatt, E Ejima.   

Abstract

Adult T-cell leukemia (ATL) associated with HTLV-1 infection is characterized by the development of hypercalcemia in over two thirds of patients. Dysregulation of cellular gene transcription by viral proteins is an emerging paradigm for molecular pathogenesis of disease. A recent example is the parathyroid hormone-related protein (PTHrP) gene, which has been implicated in the hypercalcemia of ATL, and is transactivated by the HTLV-1 tax and HTLV-11 tax proteins. PTHrP is expressed at high levels in leukemia cells derived from ATL patients, as well as in asymptomatic HTLV-1 positive carriers. This article reviews the interaction of the HTLV-1 transcriptional regulator tax with the PTHrP promoter. Tax mediates its effects on PTHrP via cellular transcription factors AP-2 and AP-1, and transactivation via an AP-2 motif represents a novel interaction of tax with a cellular transcription factor.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7812198     DOI: 10.3109/10428199409049695

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  14 in total

Review 1.  Notch and the regulation of osteoclast differentiation and function.

Authors:  Jungeun Yu; Ernesto Canalis
Journal:  Bone       Date:  2020-06-08       Impact factor: 4.398

2.  Effects of parathyroid hormone-related protein and macrophage inflammatory protein-1α in Jurkat T-cells on tumor formation in vivo and expression of apoptosis regulatory genes in vitro.

Authors:  Sherry T Shu; Wessel P Dirksen; Lisa G Lanigan; Chelsea K Martin; Nanda K Thudi; Jillian L Werbeck; Soledad A Fernandez; Blake E Hildreth; Thomas J Rosol
Journal:  Leuk Lymphoma       Date:  2012-01-03

Review 3.  Notch Signaling and the Skeleton.

Authors:  Stefano Zanotti; Ernesto Canalis
Journal:  Endocr Rev       Date:  2016-04-13       Impact factor: 19.871

Review 4.  Vitamin D-Mediated Hypercalcemia: Mechanisms, Diagnosis, and Treatment.

Authors:  Peter J Tebben; Ravinder J Singh; Rajiv Kumar
Journal:  Endocr Rev       Date:  2016-09-02       Impact factor: 19.871

5.  Humoral hypercalcemia of malignancy: severe combined immunodeficient/beige mouse model of adult T-cell lymphoma independent of human T-cell lymphotropic virus type-1 tax expression.

Authors:  V Richard; M D Lairmore; P L Green; G Feuer; R S Erbe; B Albrecht; C D'Souza; E T Keller; J Dai; T J Rosol
Journal:  Am J Pathol       Date:  2001-06       Impact factor: 4.307

6.  Parathyroid hormone-related protein promotes bone loss in T-cell leukemia as well as in solid tumors.

Authors:  Nicole A Kohart; Said M Elshafae; Aylin A Demirer; Wessel P Dirksen; Justin T Breitbach; Sherry T Shu; Jingyu Xiang; Katherine N Weilbaecher; Thomas J Rosol
Journal:  Leuk Lymphoma       Date:  2019-10-08

7.  A novel bioluminescent mouse model and effective therapy for adult T-cell leukemia/lymphoma.

Authors:  Sherry T Shu; Murali V P Nadella; Wessel P Dirksen; Soledad A Fernandez; Nanda K Thudi; Jillian L Werbeck; Michael D Lairmore; Thomas J Rosol
Journal:  Cancer Res       Date:  2007-12-15       Impact factor: 12.701

8.  Dual-Positive (CD4+/CD8+) Acute Adult T-Cell Leukemia/Lymphoma Associated with Complex Karyotype and Refractory Hypercalcemia: Case Report and Literature Review.

Authors:  Shahzad Raza; Seema Naik; Venkat P Kancharla; Fekade Tafera; Madhumati R Kalavar
Journal:  Case Rep Oncol       Date:  2010-12-21

9.  HTLV-1-associated adult T cell leukemia lymphoma presenting as granulomatous pneumocystis jiroveci pneumonia (PJP) and hypercalcemia.

Authors:  Sabiha Shahnaz; David Reich; Diana Arévalo-Valencia; Slavka Kucinska; Joanna Tulczynska; Jean Fleischman
Journal:  J Gen Intern Med       Date:  2007-03       Impact factor: 5.128

10.  Pathogenesis of Metastatic Calcification and Acute Pancreatitis in Adult T-Cell Leukemia under Hypercalcemic State.

Authors:  Masachika Senba; Kioko Kawai; Naoki Mori
Journal:  Leuk Res Treatment       Date:  2011-12-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.